Wow - 2013.
Didn't realise how long it's been in use in Japan.
They must be doing something right for it to be in use for so long. And of course efficacy isn't in question in Japan, nor in the US.
And MSB feel they have addressed clinical and potency items.
Even the yahoo sharts are now bullish.
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-346
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.8¢ |
Change
0.023(2.41%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.005M | 1.056M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 93509 | 95.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 70695 | 25 |
View Market Depth
| Last trade - 15.47pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |